Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

SARMs may offer benefits by boosting muscle effects without unwanted side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Vitamin D compounds may help treat psoriasis by promoting skin cell differentiation.

Synthetic hormone treatment reduces melanin and hair growth in rats.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The supplement did not work better than a placebo for hair loss in women over 60.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

These medications for BPH have known risks and may have new side effects.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

HST and HST/F promote hair growth and may help treat alopecia.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Dutasteride is approved to help manage prostate enlargement.